Handelsbanken Fonder AB Buys 4,100 Shares of The Ensign Group, Inc. $ENSG

Posted by Geri Gentry on May 24th, 2026

Handelsbanken Fonder AB lifted its stake in The Ensign Group, Inc. (NASDAQ:ENSG – Free Report) by 32.1% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 16,867 shares of the company’s stock after acquiring an additional 4,100 shares during the period. Handelsbanken Fonder AB’s holdings in The Ensign Group were worth $2,938,000 at the end of the most recent reporting period.

Other large investors have also recently made changes to their positions in the company. Private Trust Co. NA boosted its holdings in shares of The Ensign Group by 156.5% in the fourth quarter. Private Trust Co. NA now owns 159 shares of the company’s stock worth $28,000 after acquiring an additional 97 shares during the period. Harbor Investment Advisory LLC boosted its holdings in shares of The Ensign Group by 125.6% in the fourth quarter. Harbor Investment Advisory LLC now owns 194 shares of the company’s stock worth $34,000 after acquiring an additional 108 shares during the period. Root Financial Partners LLC bought a new position in shares of The Ensign Group in the third quarter worth $35,000. Larson Financial Group LLC boosted its holdings in shares of The Ensign Group by 76.9% in the third quarter. Larson Financial Group LLC now owns 207 shares of the company’s stock worth $36,000 after acquiring an additional 90 shares during the period. Finally, Caitlin John LLC bought a new position in shares of The Ensign Group in the third quarter worth $39,000. 96.12% of the stock is owned by institutional investors.

The Ensign Group Price Performance

NASDAQ:ENSG opened at $171.94 on Friday. The firm has a market capitalization of $10.05 billion, a price-to-earnings ratio of 28.00, a P/E/G ratio of 1.69 and a beta of 0.73. The Ensign Group, Inc. has a 52-week low of $134.79 and a 52-week high of $218.00. The stock has a fifty day moving average of $192.17 and a 200 day moving average of $188.61. The company has a debt-to-equity ratio of 0.06, a quick ratio of 1.56 and a current ratio of 1.56.

The Ensign Group (NASDAQ:ENSG – Get Free Report) last posted its quarterly earnings data on Thursday, April 30th. The company reported $1.85 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.79 by $0.06. The company had revenue of $1.39 billion during the quarter, compared to analyst estimates of $1.40 billion. The Ensign Group had a return on equity of 16.78% and a net margin of 6.89%.The firm’s quarterly revenue was up 18.4% on a year-over-year basis. During the same quarter last year, the company earned $1.52 earnings per share. The Ensign Group has set its FY 2026 guidance at 7.480-7.620 EPS. On average, research analysts expect that The Ensign Group, Inc. will post 6.79 EPS for the current fiscal year.

The Ensign Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, April 30th. Investors of record on Tuesday, March 31st were paid a dividend of $0.065 per share. The ex-dividend date of this dividend was Tuesday, March 31st. This represents a $0.26 annualized dividend and a yield of 0.2%. The Ensign Group’s dividend payout ratio (DPR) is currently 4.23%.

Insider Buying and Selling at The Ensign Group

In other The Ensign Group news, Director John O. Agwunobi sold 392 shares of The Ensign Group stock in a transaction dated Monday, April 20th. The stock was sold at an average price of $199.97, for a total transaction of $78,388.24. Following the completion of the sale, the director owned 9,295 shares of the company’s stock, valued at $1,858,721.15. The trade was a 4.05% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Barry M. Smith sold 700 shares of The Ensign Group stock in a transaction dated Monday, May 4th. The stock was sold at an average price of $182.21, for a total value of $127,547.00. Following the sale, the director directly owned 22,052 shares of the company’s stock, valued at approximately $4,018,094.92. This trade represents a 3.08% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 2,592 shares of company stock valued at $512,364 in the last three months. 4.00% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

A number of equities analysts have recently commented on the company. Zacks Research lowered The Ensign Group from a “strong-buy” rating to a “hold” rating in a report on Monday, April 6th. Truist Financial set a $215.00 price target on The Ensign Group and gave the stock a “hold” rating in a report on Friday, February 6th. Weiss Ratings reaffirmed a “buy (b)” rating on shares of The Ensign Group in a report on Tuesday, April 21st. Royal Bank Of Canada reissued an “outperform” rating and set a $222.00 price objective (up from $206.00) on shares of The Ensign Group in a research note on Monday, February 9th. Finally, UBS Group set a $230.00 price objective on The Ensign Group and gave the company a “buy” rating in a research note on Friday, February 6th. Four investment analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. Based on data from MarketBeat.com, The Ensign Group currently has a consensus rating of “Moderate Buy” and an average target price of $216.75.

View Our Latest Analysis on The Ensign Group

The Ensign Group Company Profile

(Free Report)

The Ensign Group, Inc is a diversified provider of post-acute healthcare services in the United States, operating a network of skilled nursing, assisted living, independent living, home health and hospice care centers. The company’s model emphasizes integrated care by employing multidisciplinary teams—including nursing staff, therapists and physicians—to deliver personalized rehabilitation and long-term care services for seniors and other patients recovering from injury, illness or surgery.

Through its owned and managed centers, The Ensign Group offers a broad spectrum of rehabilitation services such as physical, occupational and speech therapy.